Lantheus Holdings (LNTH) Operating Expenses (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Operating Expenses of $96.9 million for Q1 2026, down 2.42% year-over-year from $99.3 million in Q1 2025, and up 288.99% quarter-over-quarter from -$51.3 million in Q4 2025.
Lantheus Holdings (LNTH) Operating Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Operating Expenses for 13 consecutive years, with $96.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 2.42% year-over-year to $96.9 million; the TTM figure through Mar 2026 stood at $283.1 million (down 38.22% YoY), while the FY2025 annual figure was $286.3 million, down 20.86% from the prior year.
- Operating Expenses grew to $96.9 million in Q1 2026 per LNTH's latest filing, from -$51.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $260.2 million in Q4 2022 and bottomed at -$51.3 million in Q4 2025.
- Historically, Operating Expenses has averaged $89.2 million across 5 years, with a median of $76.5 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 344.78% — and 2025, when it tumbled 126.99%.
- Lantheus Holdings' Operating Expenses stood at $260.2 million in 2022, then plunged by 53.44% to $121.1 million in 2023, then soared by 56.81% to $190.0 million in 2024, then tumbled by 126.99% to -$51.3 million in 2025, then surged by 288.99% to $96.9 million in 2026.
- Business Quant data shows LNTH's Operating Expenses at $96.9 million in Q1 2026, -$51.3 million in Q4 2025, and $129.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.95 Bn | 241.86 Mn | 103.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.44 Mn |
| Mar 31, 2026 | 96.91 Mn |
| Dec 31, 2025 | -51.28 Mn |
| Sep 30, 2025 | 129.92 Mn |
| Jun 30, 2025 | 107.56 Mn |
| Mar 31, 2025 | 99.32 Mn |
| Dec 31, 2024 | 189.97 Mn |
| Sep 30, 2024 | 76.52 Mn |
| Jun 30, 2024 | 92.44 Mn |
| Mar 31, 2024 | 75.90 Mn |
| Dec 31, 2023 | 121.15 Mn |
| Sep 30, 2023 | 73.14 Mn |
| Jun 30, 2023 | 42.05 Mn |
| Mar 31, 2023 | 55.89 Mn |
| Dec 31, 2022 | 260.18 Mn |
| Sep 30, 2022 | 49.17 Mn |
| Jun 30, 2022 | 47.33 Mn |
| Mar 31, 2022 | 49.79 Mn |
| Dec 31, 2021 | 58.50 Mn |
| Sep 30, 2021 | 39.80 Mn |